Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Propagated in: Rhesus monkey kidney cells in tissue culture
Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus
Name of Depositor
NIH/NIAID
Source
Rhesus monkey immune serum prepared against coxsackievirus type A-16 strain G-10
References
Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925
Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414
